Prostate Cancer
Tumor volume in insignificant prostate cancer: Increasing threshold gains increasing risk - Abstract
November 26, 2014
Impact of the 2008 U.S. Preventative Services Task Force recommendation on frequency of prostate-specific antigen screening in older men - Abstract
November 26, 2014
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer - Abstract
November 26, 2014
Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk - Abstract
November 26, 2014
Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy - Abstract
November 26, 2014
Focal therapy: Patients, interventions, and outcomes-A report from a consensus meeting - Abstract
November 26, 2014
Prevention and early detection of prostate cancer - Abstract
November 26, 2014
Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment - Abstract
November 25, 2014
Variability in date of prostate cancer diagnosis: A comparison of cancer registry, pathology report, and electronic health data sources - Abstract
November 25, 2014
Biopsy sampling and histopathological markers for diagnosis of prostate cancer - Abstract
November 24, 2014
Sexual partners, sexually transmitted infections, and prostate cancer risk - Abstract
November 24, 2014
The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy - Abstract
November 24, 2014
Prostate specific antigen. Current clinical application and future prospects - Abstract
November 24, 2014
The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy - Abstract
November 24, 2014
From bench to bedside: Immunotherapy for prostate cancer - Abstract
November 24, 2014